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BACKGROUND. The inanimate hospital environment has emerged as an important reservoir of nosocomial pathogens. In particular, 
multidrug-resistant pathogens, such as methicillin-resistant Staphylococcus aureus, Acinetobacter species, and Clostridium difficile, play a 
major role in the transmission of hospital-acquired infections. In Europe, aldehydes, chlorine, and quaternary ammonium compounds 
have been commonly used for environmental disinfection. Glucoprotamin, a newer active compound for disinfectants, has been clinically 
tested for disinfection of instruments but not for environmental disinfection. 
OBJECTIVE. This study evaluated the antimicrobial effectiveness of a glucoprotamin-containing product (Incidin) compared with that 
of an aldehyde-containing product (Deconex), the current standard at our institution. 
METHODS. This prospective crossover study was conducted in our access-restricted hematologic transplant unit. A total of 3,086 samples 
from the environment were processed and examined for overall bacterial burden as well as selectively for S. aureus, C. difficile, and gram-
negative bacteria. 
RESULTS. There was no significant difference in residual bacteria after disinfection between the 2 products in terms of overall burden 
and selected pathogens. Enterococci were the predominant pathogens recovered from surfaces, but no vancomycin-resistant enterococci 
were recovered. Similarly, C. difficile could not be found in the patients' environment, even in rooms, despite the use of selective media. 
CONCLUSION. The aldehyde-containing product (Deconex) and the glucoprotamin-containing product (Incidin) demonstrated similar 
efficacy against environmental contamination in a hematologic transplant unit with the application of selective media for C. difficile, S. 
aureus, and gram-negative bacteria in addition to standard medium. 
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The inanimate hospital environment has been identified as 
an important reservoir of nosocomial pathogens.1,2 The en-
vironment of a patient's room becomes contaminated es-
pecially in situations when patients suffer from infections with 
methicillin-resistant Staphylococcus aureus (MRSA) or van-
comycin-resistant enterococci (VRE). Environmental clean-
ing has experienced a renaissance in recent years as a measure 
to reduce healthcare-acquired infections.3 The role of routine 
surface disinfection of all parts of a hospital has been debated 
controversially in the past.4 Routine surface disinfection has 
been recommended for high-risk settings.5 Traditionally, al-
dehydes as broad-spectrum microbicides have been used for 
surface disinfection, especially in Europe. Glucoprotamin has 
been introduced as an active compound (AC) for aldehyde-
free disinfectants.6 Unlike aldehydes, it does not evaporate, 
and it has shown good in vitro efficacy against multidrug-
resistant clinical strains7 and has performed well in tests for 
medical instruments.8 
However, in-practice data for surface disinfection are lack-
ing. Therefore, we initiated a crossover study to evaluate the 
effectiveness of Incidin (which contains glucoprotamin) rel-
ative to the current standard, Deconex (which contains al-
dehyde), in a high-risk clinical setting. 
M E T H O D S 
Setting 
The study was conducted at the hematologic transplant unit 
of the University Hospital Basel, Basel, Switzerland. Approx-
imately 70 patients a year undergo stem-cell transplantation 
or high-dose chemotherapy with prolonged neutropenia, with 
an average stay of 4-6 weeks. Access is restricted. All rooms 
are single rooms and are provided with HEPA-filtered air, 
and healthcare workers wear protective clothing. The com-
position of the floor of the ward is PVC, and bathrooms are 
tiled. 
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Study Design 
The study was a prospective crossover study conducted from 
October through December 2010. The study unit was split 
into 2 equal parts: one part was disinfected using aldehyde-
containing disinfectant (Deconex), while the other was al-
located to a glucoprotamin-containing disinfectant (Incidin). 
The first part of the study lasted 4 weeks. Before switching 
products, a washout phase of 1 day was performed using a 
detergent. After this cleaning, the 2 disinfectants were used 
crossover for another 4 weeks. 
Disinfectants and Disinfection Regime 
The aldehyde-containing disinfectant (Deconex 50 FF; Borer 
Chemie) contained 12.0 g of glyoxal (ethanedial), 0.5 g of 
glutaraldehyde (pentanedial), and 7.5 g of didecyldimethyl-
ammoniumchloride per 100 g. The glucoprotamin-containing 
disinfectant (Incidin PLUS; Ecolab) contained 26 g of gluco-
protamin per 100 g. The concentration recommended by the 
manufacturer for hospital use for a 1-hour exposure was 0.5%. 
The disinfectants were freshly prepared in the morning, 
and all touch surfaces and floors in the patient rooms were 
disinfected daily with the corresponding disinfectant. The 
unit has a designated cleaning staff, and the majority of the 
housekeeping personnel have been working for more than 5 
years in this unit. 
Hospital policy requires the use of a disinfectant active 
against spores when Clostridium difficile polymerase chain 
reaction ribotype 027 is isolated.9 Rooms given this treatment 
were excluded from the study. 
Sampling and Incubation 
Sampling sites in rooms were as follows: the table used by 
staff (sample size, 10 x 10 cm), the electric bed control panel 
(whole surface, approximately 5 x 10 cm), the cold water 
faucet in the patient's bathroom (sphere, diameter of 5 cm), 
the table used by the patient (sample size, 10 x 10 cm), and 
the floor close to the patient's bed (sample size, 10 x 10 
cm). Sampling was done every other day in the morning after 
disinfection. The time between disinfection and sampling was 
recorded. The sampling sites were swabbed with premoist-
ened (0.9% NaCl) swabs (Unomedical). Swabs were vortexed 
in 2 mL of neutralizing solution, and 0.2 mL was plated on 
each medium. 
The neutralizing solutions were validated for both disin-
fectants, and nontoxicity was proved. The following neu-
tralizing solutions were used as recommended by the man-
ufacturers: for Deconex (aldehyde), 3% Tween 80, 3% 
saponin, 0.1% histidine, and 0.1% cysteine; and for Incidin 
(glucoprotamin), 3% Tween 80, 3% saponin, 0.3% lecithin, 
0.1% histidine, and 0.5% sodium thiosulfate. 
Microbiology 
The following media were used: Columbia agar (Becton 
Dickinson) with 5% sheep blood for total colony count, 
CHROMAgar orientation medium (Becton Dickinson) for 
gram-negative bacteria, BBL CHROMAgar S. aureus (Becton 
Dickinson), and Clostridium agar CLO (bioMerieux) for C. 
difficile. Incubation details were as follows: 36°C for 48 hours; 
for Columbia agar, C02 atmosphere; and for Clostridium agar, 
anaerobic conditions. 
Molecular Typing 
All strains of Pseudomonas aeruginosa, C. difficile, MRSA, and 
other multidrug-resistant pathogens were characterized by 
molecular typing (pulsed-field gel electrophoresis [PFGE]). 
Statistical Analysis 
Data were entered into a spreadsheet (Excel; Microsoft) and 
then imported into SPSS 19. Univariate analysis was per-
formed using the x2 test or the Fisher exact test, where ap-
propriate, for categorical variables and the 2-tailed Student 
t test or the Kolmogorov-Smirnov test for continuous vari-
ables. Differences with P < .05 were regarded as statistically 
significant. 
RESULTS 
Of a total of 3,068 analyzed samples obtained, 1,528 were 
from surfaces disinfected with Deconex (AC aldehyde), and 
1,540 were from surfaces disinfected with Incidin (AC glu-
coprotamin). One hundred fifty-two (9.9%) samples from 
aldehyde-disinfected surfaces and 185 (12.0%) samples from 
glucoprotamin-disinfected surfaces showed growth (P = 
.067). The bacterial counts on positive environmental sites 
were not statistically different (P — .58; Table 1) for both 
tested products. 
Gram-negative bacteria were found in 1 sample (Entero-
bacter aerogenes), from a floor treated with Incidin (6 colony-
forming units [CFUs]/100 cm2). P. aeruginosa was found on 
a faucet. This strain was identical with a patient's isolate from 
rectal screening, confirmed by identical PFGE pattern. How-
ever, there was no evidence for P. aeruginosa infection. 
S. aureus was isolated twice from floors disinfected with 
Deconex as well as twice from a floor, twice from a bed control 
panel, and once from a water faucet disinfected with Incidin. 
C. difficile was not detected in any samples, despite the fact 
that clinical cases occurred during the study and that selective 
culture medium was used. 
Enterococci (E. faecalis and E. faecium) were the most fre-
quently encountered pathogens, detected in 3% (glucopro-
tamin disinfection, n = 328) and 6% (aldehyde disinfection, 
n = 290) of all environmental samples (P — .14). High 
numbers (up to 8,000 CFUs/100 cm2) of enterococci could 
be detected even shortly after disinfection (60 min). 
D I S C U S S I O N 
No significant difference in the antimicrobial effectiveness 
between the commonly used Deconex (AC aldehyde) and 
Incidin (AC glucoprotamin) was found (Table 1), despite the 
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TABLE 1. Bacterial Counts on Positive Environmental Sites after Surface Disinfection 
Sample site 
Overall 
Staff table 
Bed control panel 
Water faucet 
Patient table 
Floor 
Deconex (AC aldehyde) 
CFUs/100 cm2, 
mean ± SD (n = 61a) 
645 ± 1,387 
51 ± 300 
13,220 ± 33,995 
11,480 ± 32,134 
158 ± 1,022 
325 ± 638 
% negative 
samples 
46 
74 
53 
57 
59 
26 
Incidin (AC glucopro 
CFUs/100 cm2, 
mean ± SD (« = 67a) 
1,729 ± 4,890 
1,642 ± 12,217 
6,483 ± 23,874 
7,478 ± 26,472 
1,828 ± 12,252 
713 ± 2,578 
tamin) 
% negative 
samples 
53 
46 
60 
57 
47 
25 
P 
.580" 
.290 
.201 
.446 
.270 
.237 
NOTE. AC, active compound; CFU, colony-forming unit; SD, standard deviation. 
" Quantitative cultures analyzed. 
b
 P = .075 for negative samples. 
large sample size. Several studies have not been able to show 
a difference between thorough cleaning with a detergent and 
cleaning with a disinfectant.4'5'910 Recolonization shortly after 
disinfection was documented by Dharan et al,4 who postu-
lated the need for disinfection of patients' environments more 
frequently than once daily. However, these studies did not 
use selective media to detect clinically important pathogens. 
While it is obvious that the inanimate environment can 
be a source of nosocomial pathogens, clear guidance on the 
limits of microbial contamination of inanimate surfaces in 
hospital settings is lacking. Dancer10 suggested a limit of less 
than 5 CFUs/cm2 for frequent hand-contact surfaces in hos-
pitals." In our study, we found results exceeding this limit 
even 60 minutes after disinfection, especially on the floor and 
on sites near patients (patient table and bed control panel). 
Some limitations to this study should be mentioned. A 
standardization of sampling times was not feasible. However, 
our study design using multiple time points allowed us to 
show recontamination of the environment over time. Al-
though patients are exposed to their environment 24 hours 
a day, routine surveillance could not document a clinical 
infection from the environmental source. In contrast, a pa-
tient infected with 5. aureus contaminated his environment 
in 3 samples (floor and bed control panel). 
No gram-negative bacteria were detected from the envi-
ronment, except for 1 strain of E. aerogenes. Of the positive 
clinical patient specimens obtained on the ward, 21% showed 
gram-negative bacteria (data not shown); however, we could 
not identify Escherichia coli or Klebsiella species from the 
environment. This might be due to the short survival times 
of some of the gram-negative bacteria1 and to the stringent 
and thorough daily cleaning regimen. 
One patient had toxin-positive C. difficile diarrhea during 
the study, potentially exposing the environment.12 However, 
none of the environmental samples revealed C. difficile despite 
the use of selective culture medium. Neither disinfectant has 
sporicidal efficacy under the conditions applied in this study. 
A good subjective cleaning efficacy of both products was re-
ported by the cleaning staff and in combination with the strin-
gent and thorough daily cleaning regimen may have contrib-
uted to the absence of C. difficile. In fact, thorough cleaning 
without a disinfectant can remove more than 95% of spores.1013 
However, these data call into question whether sporicidal ac-
tivity is required in a nonepidemic setting,14 and further re-
search would certainly be needed to explain these findings.15 
Enterococci were isolated from the environment even 
shortly after disinfection, as already observed by Weber and 
Rutala16 and Anderson et al17 for VRE. A stricter adherence 
to disinfection protocols was therefore recommended by An-
derson et al.17 VRE are becoming more and more problematic 
in hospitals and cause epidemic outbreaks, even though not 
all VRE are associated with outbreaks.17 The frequent isolation 
of enterococci after disinfection may be due to recontami-
nation or emergence of resistance to the disinfectant. In 3% 
of clinical specimens from the ward, enterococci were found; 
no VRE were reported during the study period (data not 
shown). We have tested 3 strains according to EN 1040,18,19 
and no evidence for resistance to Deconex or Incidin was 
found. Similarly, Anderson et al17 and Tyski et al7 could show 
that VRE were susceptible to a spectrum of hospital-grade 
disinfectants, and they could not find a link between resis-
tance to vancomycin and germicides. 
In summary, the aldehyde-containing product and the glu-
coprotamin-containing product demonstrated similar efficacy 
against environmental contamination in a high-risk hospital 
environment, despite the use of selective media for C. difficile, 
S. aureus, and gram-negative bacteria in addition to standard 
medium. C. difficile was not detected even though glucopro-
tamin is not active against spores, possibly because of daily 
cleaning by in-house staff. 
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